As of 3:52pm ET
| -0.10 / -5.88%|
The 3 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 5.00, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +212.50% increase from the last price of 1.60.
The current consensus among 3 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.